21OH - Overview: 21-Hydroxylase Antibodies, Serum
Investigating adrenal insufficiency Aiding in the detection of those at risk of developing autoimmune adrenal failure in the future
VALPF - Overview: Valproic Acid, Free, Serum
Monitoring free valproic acid in therapy Assessing compliance Evaluating potential toxicity
VLTB - Overview: Volatile Screen, Blood
Detection and quantitation of acetone, methanol, isopropanol, and ethanol in whole blood Quantification of the concentration of ethanol in blood that correlates with the degree of intoxication Evaluation of toxicity to the measured...
VALPA - Overview: Valproic Acid, Total, Serum
Monitoring total valproic acid in therapy Assessing compliance Evaluating potential toxicity
CD21 - Overview: CD21 Immunostain, Technical Component Only
Identification of follicular dendritic cells and a subset of mantle zone lymphocytes
PTSC - Overview: Prothrombin Time (PT), Plasma
Screening to identify a deficiency of one or more of the clotting factors of the extrinsic coagulation system (I, II, V, VII, X) due to hereditary deficiency or acquired conditions such as liver disease, vitamin K deficiency, or a specific...
UPHB - Overview: pH, Body Fluid
Indicating the presence of infections or fistulas Verifying the effectiveness of treatment to reduce stomach pH Diagnosing disease states characterized by abnormal stomach acidity This test is not appropriate for measurement of...
APBTS - Overview: Adaptor Protein 3 Beta2 (AP3B2) Antibody, Tissue Immunofluorescence Titer, Serum
The differential diagnosis of patients presenting with mixed cerebellar and sensory ataxia and myeloneuropathy Reporting an end titer result from serum specimens
Detecting tripartite motif-containing protein 46 (TRIM46)-IgG by cell-binding assay using cerebrospinal fluid specimens Evaluation of an autoimmune/paraneoplastic neurological syndrome among patients presenting with cerebellar ataxia,...
TLUCR - Overview: Thallium/Creatinine Ratio, Random, Urine
Detecting toxic thallium exposure in random urine specimens
HSTNI - Overview: Troponin I, High Sensitivity, Plasma
Excluding the diagnosis of acute coronary syndromes Explaining troponin T elevations related to skeletal myopathy and/or assay interferences
THEVI - Overview: Hemoglobinopathy Interpretation
Interpretation of results for the evaluation of thalassemias and hemoglobinopathies Evaluation of microcytosis Extensive and economical diagnosis and classification of hemoglobinopathies or thalassemia including complex...
EXHR - Overview: Hematologic Disorders, DNA and RNA Extract and Hold, Varies
Reserving nucleic acids on any specimen for which molecular analysis requiring DNA or RNA may be necessary at a future date, ensuring that adequate material for testing is available
EXHD - Overview: Hematologic Disorders, DNA Extract and Hold, Varies
Reserving DNA on any specimen for which molecular analysis requiring DNA may be necessary at a future date, ensuring that adequate material for testing is available
GENTA - Overview: Gentamicin, Trough, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
GGT - Overview: Gamma-Glutamyltransferase (GGT), Serum
Diagnosing and monitoring hepatobiliary disease, it is currently the most sensitive enzymatic indicator of liver disease Ascertaining whether observed elevations of alkaline phosphatase are due to skeletal disease (normal...
FLUOX - Overview: Fluoxetine, Serum
Monitoring serum concentration of fluoxetine during therapy Evaluating potential toxicity Evaluating patient compliance
GBETH - Overview: General Factor Bethesda Units, Plasma
Detecting and quantifying the presence and titer of a specific factor inhibitor directed against a specific coagulation factor
GPI1 - Overview: Glucose Phosphate Isomerase Enzyme Activity, Blood
The evaluation of individuals with Coombs-negative chronic hemolysis
GD65C - Overview: Glutamic Acid Decarboxylase (GAD65) Antibody Assay, Spinal Fluid
Possible use in evaluating patients with autoimmune encephalitis, stiff-person syndrome, autoimmune ataxia, autoimmune epilepsy, and other acquired central nervous system disorders affecting gabaminergic neurotransmission
TULI - Overview: Francisella tularensis Antibody, IgM and IgG, Technical Interpretation, Serum
Interpretation to aid in the diagnosis of tularemia caused by Francisella tularensis
GENPA - Overview: Gentamicin, Peak, Serum
Monitoring adequacy of drug clearance during gentamicin therapy
GENRA - Overview: Gentamicin, Random, Serum
Monitoring adequacy of serum concentration during gentamicin therapy in specimens for which no collection timing information is provided
GQ1ES - Overview: Ganglioside GQ1b Antibody, IgG, ELISA, Serum
Evaluating patients with an underlying demyelinating neuropathy Supporting the diagnosis of a ganglioside GQ1b IgG-related disorder
GABA - Overview: Gabapentin, Serum
Monitoring serum gabapentin concentrations Assessing compliance Adjusting dosage in patients
LD - Overview: Lactate Dehydrogenase (LDH), Serum
Investigation of a variety of diseases involving the heart, liver, muscle, kidney, lung, and blood Monitoring changes in tumor burden after chemotherapy; lactate dehydrogenase elevations in patients with cancer are too erratic to be of use...
IRF8 - Overview: Interferon Regulatory Factor 8 (IRF8) Immunostain, Technical Component Only
Identification of monoblasts in acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia
LEFLU - Overview: Leflunomide Metabolite (Teriflunomide), Serum
Therapeutic monitoring of patients actively taking leflunomide Assessment of elimination in patients requiring enhanced elimination of the drug
LEIS - Overview: Leishmaniasis (Visceral) Antibody, Serum
Aiding in the diagnosis of active visceral leishmaniasis This test should not be used as the sole criteria for diagnosis.
ACE - Overview: Angiotensin Converting Enzyme, Serum
Evaluation of patients with suspected sarcoidosis
MMLRG - Overview: Antimicrobial Susceptibility, Acid-Fast Bacilli, Rapidly Growing, Varies
Determination of susceptibility of rapidly growing mycobacteria to the antimicrobial agents on the test panel
ASB - Overview: Arsenic, Blood
Detecting acute or very recent arsenic exposure Monitoring the effectiveness of therapy This test is not useful for evaluation of chronic arsenic exposure.
ANNEX - Overview: Annexin-1 Immunostain, Technical Component Only
Classification of leukemias
APTTP - Overview: Activated Partial Thromboplastin Time, Plasma
Monitoring heparin therapy (unfractionated heparin) Screening for certain coagulation factor deficiencies Detection of coagulation inhibitors such as lupus anticoagulant, specific factor inhibitors, and nonspecific inhibitors
ADLTX - Overview: Adulterants Survey, Chain of Custody, Random, Urine
Assess the possible adulteration of a urine specimen submitted for drug of abuse testing Providing the urine creatinine concentration for normalization purposes Chain of custody is required whenever the results of testing could be used...
BRIVA - Overview: Brivaracetam, Plasma
Assessing compliance and toxicity for brivaracetam
BRUTA - Overview: Brucella Total Antibody Confirmation, Agglutination, Serum
Diagnosis of brucellosis
CARU - Overview: Cyclic Adenosine Monophosphate (cAMP), Urinary Excretion, Serum and Urine
Differential diagnosis of hypercalcemia As an adjunct to serum parathyroid hormone measurements, especially in the diagnosis of parathyroid hormone resistance states, such as pseudohypoparathyroidism
CRTFR - Overview: Creatinine, Random, Urine
Normalizing urinary analytes to account for the variation in urinary concentrations between individuals when using random urine collections
CYSR - Overview: Cystinuria Profile, Quantitative, Random, Urine
Biochemical diagnosis of cystinuria using random urine specimens
MTHX - Overview: Methotrexate, Serum
Determining whether methotrexate is being cleared appropriately and verifying that a nontoxic concentration has been attained following therapy
MGS - Overview: Magnesium, Serum
Monitoring preeclampsia patients being treated with magnesium sulfate, although in most cases monitoring clinical signs (respiratory rate and deep tendon reflexes) is adequate and blood magnesium levels are not required
NCDTC - Overview: Neurochondrin Antibody, Tissue Immunofluorescence Titer, Spinal Fluid
Detecting neurochondrin-IgG in spinal fluid (CSF) from patients presenting with cerebellar and brainstem syndrome Reporting an end titer result from CSF specimens
NF4FS - Overview: Neurofascin-155 IgG4, Flow Cytometry, Serum
Evaluating patients with an underlying demyelinating neuropathy Diagnosis of a neurofascin-155 IgG4 mediated neuropathy
OMHC - Overview: Oxcarbazepine Metabolite, Serum
Monitoring serum concentration during oxcarbazepine therapy Assessing compliance Assessing potential toxicity
SEMA3 - Overview: Semaphorin 3B (SEMA3B) Immunostain, Technical Component Only
Aiding in the diagnosis of semaphorin 3B-associated membranous nephropathy
SPNEU - Overview: Streptococcus pneumoniae Antigen, Random, Urine
Rapid diagnosis of pneumococcal pneumonia
MONOF - Overview: Monocyte Repartition by CD14/CD16, Blood
Aiding in the diagnosis and monitoring of chronic myelomonocytic leukemia
AATHI - Overview: Thrombophilia Profile Interpretation
Interpretation of testing performed as part of a profile to evaluate patients with thrombosis or hypercoagulability states including detecting a lupus-like anticoagulant; dysfibrinogenemia; disseminated intravascular...
TAKRO - Overview: Tacrolimus, Blood
Monitoring whole blood tacrolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....
The Region 4 Stork (R4S) Collaborative Project - Insights
describing the products and clinical tools of a laboratory quality improvement project called Region 4 Stork, or R4S....